Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N- succinimidyl 5-iodo-3-pyridinecarboxylate

Cancer Research

Volumn 57, Issue 8, 1997, Pages 1510-1515

  Reist, Craig J ^a   Archer, Gerald E ^a   Wikstrand, Carol J ^a   Bigner, Darell D ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLOBIOSE; EPIDERMAL GROWTH FACTOR RECEPTOR; IODINE 125; IODINE 131; MONOCLONAL ANTIBODY; NICOTINIC ACID DERIVATIVE; REAGENT; RECEPTOR ANTIBODY; SUCCINIMIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; DRUG TISSUE LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR XENOGRAFT;

3T3 CELLS; AFFINITY LABELS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; MICE; MICE, NUDE; NICOTINIC ACIDS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUCCINIMIDES; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TYRAMINE;

EID: 0030983005     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Novak-Hofer, I., Amstutz, H. P., Morgenthaler, J. J., and Schubiger, P. A. Internalization and degradation of monoclonal antibody chCE7 by human neuroblastoma cells. Int. J. Cancer, 57: 427-432, 1994.
2. Geissler, F., Anderson, S. K., and Press, O. W. Intracellular catabolism of radiolabeled anti-CD3 antibodies by leukemic T cells. Cell. Immunol., 137: 96-110, 1991.
3. Press, O. W., Farr, A. G., Borroz, K. I., Anderson, S. K., and Martin, P. J. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res., 49: 4906-4912, 1989.
4. Press, O. W., Hansen, J. A., Fair, A., and Martin, P. J. Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes. Cancer Res., 48: 2249-2257, 1988.
5. Press, O. W., Shan, D., Howell-Clark, J., Eary, J., Appelbaum, F. R., Matthews, D., King, D. J., Haines, A. M. R., Hamann, P., Hinman, L., Shochat, D., and Bernstein, I. D. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. Cancer Res., 56: 2123-2129, 1996.
6. Stein, R., Goldenberg, D. M., Thorpe, S., R., Basu, A., and Mattes, M. J. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors. Cancer Res., 55: 132-3139, 1995.
7. Thorpe, S. R., Baynes, J. W., and Chroneos, Z. C. The design and application of residualizing labels for studies of protein cataboiism. FASEB J., 7: 399-405, 1993.
8. Ali, S. A., Warren, S. D., Richter, K. Y., Badger, C. C., Eary, J. F., Press, O. W., Krohn, K. A., Bernstein, I. D., and Nelp, W. B. Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts. Cancer Res., 50: 783s-788s, 1990.
9. 125I-tyramine, an improved residualizing label for studies on sites of cataboiism of circulating proteins. J. Biol. Chem., 263: 14122-14127, 1988.
10. Reist, C. J., Archer, G. E., Kurpad, S. N., Wikstrand, C. J., Vaidyanathan, G., Willingham, M. C., Moscatello, D. K., Wong, A. J., Bigner, D. D., and Zalutsky, M. R. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts. Cancer Res., 55: 4375-4382, 1995.
11. Pittman, R. C., Carew, T. E., Glass, C. K., Green, S. R., Taylor, C. A., Jr., and Attie, A. D. A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem. J., 212: 791-800, 1983.
12. Glass. C. K., Pittman, R. C., Kellen G. A., and Steinberg, D. Tissue sites of degradation of apoprotein A-I in the rat. J. Biol. Chem., 258: 7161-7167, 1983.
13. Schilling, U., Friedrich, E. A., Sinn, H., Schrenk, H- H., Clorius, J. H., and Maier-Borst, W. Design of compounds having enhanced tumour uptake, using serum albumin as a carrier. In vivo studies. Int. J. Radiat. Appl. Instrum. Part B., 19: 685-695, 1992.
14. Moerlein, S. M., Dalal, K. B., Ebbe, S. N., Yano, Y., and Budinger, T. F. Residualizing and non-residualizing analogues of low-density lipoprotein as iodine-123 radiopharmaceuticals for imaging LDL catabolisim. Int. J. Radiat. Appl. Instrum. Part B., 15: 141-149, 1988.
15. Ali, S. A., Eary, J. F., Warren, S. D., Badger, C. C., and Krohn, K. A. Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies. Int. J. Radial. Appl. Instrum. Part B., 15: 557-561, 1988.
16. Ekstrand, A. J., Sugawa, N., James, C. D., and Collins, V. P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc. Natl. Acad. Sci. USA, 59: 4309-4313, 1992.
17. Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., and Vogelstein, B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA, 89: 2965-2969, 1992.
18. Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. L., Humphrey, P. A., Kurpad, S. N., McLendon, R. E., Moscatello, D., Pegram, C. N., Reist, C. J., Traweek, T., Wong, A. J., Zalutsky, M. R., and Bigner, D. D. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res., 55: 3140-3148, 1995.
19. Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G., Zoltick, P. W., Biegel, J. A., Hayes, R. L., and Wong, A. J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res., 55: 5536-5539, 1995.
20. Reist, C. J., Garg, P. K., Alston, K. L., Bigner, D. D., and Zalutsky, M. R. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate, Cancer Res., 56: 4970-4978, 1996.
21. Wikstrand, C. J., McLendon, R. E., Carrel, S., Kemshead, J. T., Mach, J. P., Coakham, H. B., de Tribolet, N., Bullard, D. E., Zalutsky, M. R., and Bigner, D. D. Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model. J. Neuroimmunol., 75: 37-56, 1987.
22. Yamazaki, H., Ohba, Y., Tamaoki, N., and Shibuya, M. A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn. J. Cancer Res., 81: 773-779, 1990.
23. Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., and Huang, H. J. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91: 7727-7731, 1994.
24. Garg, S., Garg, P. K., and Zalutsky, M. R. N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination. Bioconjugate Chem., 2: 50-56, 1991.
25. Garg, S., Garg, P. K., Zhao, X. G., Friedman, H. S., Bigner, D. D., and Zalutsky, M. R. Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate. Nucl. Med. Biol., 20: 835-842, 1993.
26. Fraker, P. J., and Speck, J. C., Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem. Biophys. Res. Commun., 80: 849-857, 1978.
27. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A., Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods, 72: 77-89, 1984.
28. Press, O. W., DeSantes, K., Anderson, S. K., and Geissler, F. Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores. Cancer Res., 50: 1243-1250, 1990.
29. van der Jagt, R. H., Badger, C. C., Appelbaum, F. R., Press, O. W., Matthews, D. C., Eary, J. F., Krohn, K. A., and Bernstein, I. D. Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model. Cancer Res., 52: 89-94, 1992.
30. Zalutsky, M. R. Antibody-mediated radiotherapy: future prospects. In: M. R. Zalutsky (ed.), Antibodies in Radiodiagnosis and Therapy, pp. 213-231. Boca Raton, FL: CRC Press, Inc., 1989.
31. Daghighian, F., Barendswaard, E., Welt, S., Humm, J., Scott, A., Willingham, M. C., McGuffie, E., Old, L. J., and Larson, S. M. Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody. J. Nucl. Med., 37: 1052-1057, 1996.
32. 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor. Cancer Res., 52: 121-126, 1992.
33. Novak-Hofer, I., Amstutz, H. P., Macke, H. R., Schwarzbach, R., Zimmermann, K., Morgenthaler, J. J., and Schubiger, P. A. Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells. Cancer Res., 55: 46-50, 1995.
34. Bourdon, M. A., Coleman, R. E., Blasberg, R. G., Groothuis, D. R., and Bigner, D. D. Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis. Anticancer Res., 4: 133-140, 1984.
35. Zhong, Z-D., Jadot, M., Wattiaux-DeConinck, S., and Wattiaux, R. Uptake of tyramine cellobiose by rat liver. Biochim. Biophys. Acta, 7/06: 311-316, 1992.